Paper Details

  1. Home
  2. Paper Details

Prevalence of rilpivirine resistance in people starting antiretroviral treatment in Argentina.

Author: BarbásMaria G, BissioEmiliano, BouzasMaria B, CudoláAnalia, FalistoccoCarlos, GiulianoSilvina Fernández, KademiánSilvia, SalomónHoracio

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study analyzes the prevalence of resistance mutations to newer generation non-nucleoside reverse transcriptase inhibitors (NNRTIs) in HIV-infected patients starting antiretroviral therapy (ART) in Argentina.
Paper Details　
Original Abstract of the Article :
Rilpivirine-based regimens are now preferred or alternative first-line regimens according to many HIV treatment guidelines. Recently, a surveillance study conducted in Argentina determined that prevalence of pretreatment resistance to first-generation non-nucleoside reverse transcriptase inhibitors ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.3851/IMP3147

データ提供：米国国立医学図書館（NLM）

Prevalence of Rilpivirine Resistance in People Starting Antiretroviral Treatment

The fight against HIV is a continuous journey through a challenging desert, where researchers are constantly seeking new strategies and treatments. This study investigates the prevalence of resistance to rilpivirine, a newer generation non-nucleoside reverse transcriptase inhibitor (NNRTI), in individuals starting antiretroviral treatment in Argentina. It's like carefully mapping the terrain of HIV resistance, identifying potential obstacles and challenges along the way.

Mapping the Terrain of HIV Resistance

The study reveals a concerning prevalence of pretreatment resistance to rilpivirine in Argentina, highlighting the importance of ongoing surveillance and monitoring to adapt treatment strategies accordingly. It's like identifying potential sandstorms before they hit, ensuring that we are prepared to navigate the challenges ahead.

Navigating the Shifting Sands of HIV Treatment

This research underscores the importance of continuous monitoring and adaptation in the fight against HIV. The study's findings serve as a reminder that the desert of HIV resistance is constantly evolving, requiring ongoing vigilance and adaptability to ensure effective treatment strategies.

Dr.Camel's Conclusion

This study on the prevalence of rilpivirine resistance in people starting antiretroviral treatment in Argentina highlights the importance of ongoing surveillance and monitoring in the fight against HIV. The findings underscore the need for continued vigilance and adaptability in treatment strategies to overcome the challenges of resistance. It's a reminder that the desert of HIV is vast and complex, requiring continuous exploration and innovation to find new paths towards a healthier future.

Date :
  1. Date Completed 2018-07-30
  2. Date Revised 2018-07-30
Further Info :

Pubmed ID

28234630

DOI: Digital Object Identifier

10.3851/IMP3147

Related Literature

Article Analysis
・Effects of etravirine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.